Teleflex Incorporated (TFX) is currently under investigation for potential securities fraud. The company's recent restructuring, which includes splitting into two independent businesses, has raised questions around shareholder value. Teleflex's earnings and shareholder returns have consistently trended downwards in the past three years, feeding into concerns around its ongoing fraud investigations. The company's recent move to acquire Biotronik's vascular intervention business shows its continued interest in evolving its offerings, but industry observers remain skeptical due to the firm's tumultuous fiscal performance. Teleflex's stock recently dropped significantly as the company reported revenue shortfalls and offered weak guidance. The corporation has also announced the retirement of CFO Thomas Powell. The failure to meet revenue and earnings forecasts showcases a negative outlook. Meanwhile, Teleflex maintains a regular quarterly dividend of $0.34 per share and has initiated a $300 million share buyback for its investors.
Teleflex Incorporated TFX News Analytics from Fri, 29 May 2009 16:46:54 GMT to Sat, 21 Jun 2025 06:54:42 GMT -
Rating -7
- Innovation -5
- Information 7
- Rumor -6
